–
Статьи в журналах
-
- 2018 Results of the use of ramucirumab in combination with paclitaxel or ramucirumab monotherapy as the second line treatment in patients with disseminated HER2-negative gastric or cardioesophageal junction adenocarcinoma: experience of N.N. Blokhin russian ca
- Besova N.S., Titova T.A., Trusilova E.V., Gorbunova V.A., Tryakin A.A., Gordeeva O.O., Rumyantsev A.A., Nasyrova R.Yu, Zhukova L.G., Snegovoy A.V., Artamonova E.V., Manzyuk L.V., Fedenko A.A.
- в журнале Медицинский совет, издательство ООО "Группа Ремедиум" (Москва), № 10, с. 34-40 DOI
-
- 2017 CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER
- Lyubchenko L.N., Filippova M.G., Mekhtieva N.I., Shendrikova T.A., Semaynikhina A.V., Snegovoy A.V.
- в журнале Siberian journal of oncology, том 16, № 6, с. 73-85 DOI
-
- 2017 REAL-LIFE CLINICAL UTILITY OF RAMUCIRUMAB FOR THE TREATMENT OF PATIENTS WITH DISSEMINATED GASTRIC ADENOCARCINOMA: PRELIMINARY REVIEW OF THE EXPERIENCE OF BLOKHIN RUSSIAN CANCER RESEARCH CENTRE
- Besova N.S., Titova T.A., Gorbunova V.A., Gordeeva O.O., Tryakin A.A., Snegovoy A.V., Nasyrova R.Yu, Rumyantsev A.A., Voroshilova E.A., Artamonova E.V.
- в журнале Медицинский совет, издательство ООО "Группа Ремедиум" (Москва), № 14, с. 30-38 DOI